Supplement safety · public sources

Vitamin C safety

FDA adverse-event reports, NIH guidance on interactions, and registered trials.

What public sources say about the safety of vitamin C: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.

⚠️
Research information, not medical advice. Supplements can interact with prescription medicines and affect conditions. Check with a pharmacist or your own clinician before starting or stopping one. Nothing here is a dose recommendation.

Interactions and safety, in NIH's words

Vitamin C supplements may interact with radiation therapy and medications, including chemotherapeutic agents and statins.

Vitamin C supplements have the potential to interact with several types of medications. A few examples are provided below. Individuals who are taking these medications on a regular basis should discuss their vitamin C intakes with their health care providers.

The safety and efficacy of using vitamin C and other antioxidants during cancer treatment is controversial [53,91,92]. Some data indicate that antioxidants might protect tumor cells from the action of radiation therapy and chemotherapeutic agents, such as cyclophosphamide, chlorambucil, carmustine, busulfan, thiotepa, and doxorubicin [54,91,93,94]. At least some of these data have been criticized because of poor study design [52]. Other data suggest that antioxidants might protect normal tissues from chemotherapy- and radiation-induced damage [91,93] and/or enhance the effectiveness of conventional cancer treatment [95]. However, due to the physiologically tight control of vitamin C, it is unclear whether oral vitamin C supplements could alter vitamin C concentrations enough to produce the suggested effects. Individuals who are undergoing chemotherapy or radiation should consult with their oncologist prior to taking vitamin C or other antioxidant supplements, especially in high doses [54].

Medicines covered in that section: Chemotherapy and radiation, 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins).

Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.

FDA adverse-event reports (CAERS)

Reports are not rates. CAERS counts voluntary reports to the FDA from consumers, clinicians and companies. A report means someone linked a health problem to a product, not that the product caused it. There is no denominator: how many people took the product is unknown, so these numbers cannot show how common a problem is, and they cannot be compared between products. Popular products attract more reports.
421reports naming it in a suspect product
209where the product is named for it alone
2003–2026years covered, single-ingredient reports

Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “VITAMIN C”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.

Combination products: 212 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 209 reports where a product is named for vitamin C alone. This split is made from product names and can misfile some products. Most-reported products: Vitamin C (22); Naturemade Vitamin C (21); Naturemade Vitamin C 1000 Mg (15); Nature Made Super B-Complex With Vitamin C & Folic Acid (13); Nutrilite Vitamin C Extended Release (8); Nutrilite Vitamin C Plus Extended Release (7).

Most reported reactions, single-ingredient reports
Most reported reactions (single-ingredient products)Reports
Dyspnoea37
Choking33
Foreign body19
Nausea18
Abdominal pain15
Foreign body in throat13
Diarrhoea13
Dizziness13
Oropharyngeal pain12
Dysphagia12
Pain12
Pruritus12

Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (149), Visited a Health Care Provider (41), Visited Emergency Room (39), Hospitalization (35), Life Threatening (17), Other Outcome (15), Other Serious Outcome (10), Disability (10).

Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.

Registered trials

42 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.

All supplement safety pages Non-drug evidence map